BeStock  
Stocks › Biotechnology › ASND

Ascendis Pharma A/S ASND

US equityMarket cap rank #1027Biotechnology
$252.73 −$3.23 (-1.26%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $252.73 0.00%
Open$255.44
Prev close$255.96
Day range$251.55 – $256.65
Volume602.9K
Market cap$16.63B
P/E (TTM)34.7
Dividend yield–

Analyst view

ConsensusBuy
Analysts20
Average target$320.00+26.6% vs. price
  • Buy 95%
  • Hold 5%
Low $274.00Now $252.73Avg $320.00High $356.00

Recent rating changes

The last 20 actions on file set price targets from $273.00 to $356.00, averaging $319.60.

DateFirmRatingTarget
16 Nov 2026 Citi BUY $335.00
16 Nov 2026 Barclays BUY $341.00
13 Nov 2026 TD Cowen BUY $352.00
13 Nov 2026 CCORF HOLD $274.00
13 Nov 2026 Wells Fargo BUY $330.00
13 Nov 2026 UBS BUY $315.00
13 Nov 2026 Wedbush BUY $346.00
13 Nov 2026 Morgan Stanley BUY $302.00
13 Nov 2026 Evercore BUY $356.00
13 Nov 2026 Leerink Partners BUY $326.00
13 Nov 2026 H.C. Wainwright BUY $335.00
13 Nov 2026 Barclays BUY $341.00
12 Nov 2026 BofA Securities BUY $304.00
12 Nov 2026 RBC Capital BUY $290.00
10 Nov 2026 TD Cowen BUY $352.00
9 Nov 2026 Morgan Stanley BUY $273.00
9 Nov 2026 H.C. Wainwright BUY $344.00
2 Nov 2026 Morgan Stanley BUY $273.00
26 Oct 2026 Morgan Stanley BUY $273.00
26 Oct 2026 Citi BUY $330.00

Discussion

No comments yet — be the first to weigh in on ASND.

Sign in to join the discussion.

Scroll to Top